The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Veis, D. J., Sorenson, C. M., Shutter, J. R., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80065-m · Cited by 1,628
Miyashita, T., & Reed, J. C. (1992) · PubMed · Cited by 475
Hermine, O., Haioun, C., Lepage, E., d'Agay, M., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J., Diebold, J., et al. (1996) · Blood · doi:10.1182/blood.v87.1.265.265 · Cited by 452
Hill, M., MacLennan, K., Cunningham, D., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1046.1046 · Cited by 314
Self-citationp53 in hematologic malignancies
Imamura, J., Miyoshi, I., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.8.2412.2412 · Cited by 284
Antisense oligonucleotides: towards clinical trials
Agrawal, S. (1996) · Trends in Biotechnology · doi:10.1016/0167-7799(96)10053-6 · Cited by 265
GALBRAITH, W. M., HOBSON, W. C., GICLAS, P. C., SCHECHTER, P. J., & AGRAWAL, S. (1994) · Antisense Research and Development · doi:10.1089/ard.1994.4.201 · Cited by 238
Kamada, S., Shimono, A., Shinto, Y., Tsujimura, T., Takahashi, T., Noda, T., Kitamura, Y., Kondoh, H., & Tsujimoto, Y. (1995) · PubMed · Cited by 225
Cited by
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Apoptosis and cancer: the genesis of a research field
Cotter, T. G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2663 · Cited by 758
Nucleic-acid therapeutics: basic principles and recent applications
Opalinska, J. B., & Gewirtz, A. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd837 · Cited by 537
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., Van Elsas, A., Müller, M., Wolff, K., Eichler, H.-G., & Pehamberger, H. (1998) · Nature Medicine · doi:10.1038/nm0298-232 · Cited by 481
Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents
Vickers, T. A., Koo, S., Bennett, C. F., Crooke, S. T., Dean, N. M., & Baker, B. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210326200 · Cited by 461
Metadata
- Authors
- Webb, A., Cunningham, D., Cotter, F., Clarke, P., Di Stefano, F., Ross, P., Corbo, M., & Dziewanowska, Z.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-04
- Volume
- 349
- Issue
- 9059
- Pages
- 1137-1141
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2135368384
- Cited by
- 489
- References
- 14
- FWCI
- 39.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. https://app.cochat.ai/papers/10.1016/s0140-6736(96)11103-x
- The paper
- Webb, A., Cunningham, D., Cotter, F., Clarke, P., Di Stefano, F., Ross, P., Corbo, M., & Dziewanowska, Z. (1997). BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. The Lancet. https://doi.org/10.1016/s0140-6736(96)11103-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
